Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | CAV1 |
| Upstream (Parents) |
|---|
| (<<) AKAP12 → CAV1 |
| (<<) ANTXR2 → CAV1 |
| (<<) CCND2 → CAV1 |
| (<<) CLDN5 → CAV1 |
| (<<) EFEMP2 → CAV1 |
| (<<) HS2ST1 → CAV1 |
| (<<) IGFBP4 → CAV1 |
| (<<) IGFBP7 → CAV1 |
| (<<) MMP2 → CAV1 |
| (<<) RECK → CAV1 |
| (<<) RRP9 → CAV1 |
| Downstream (Children) |
|---|
| CAV1 → ARL4C (>>) |
| CAV1 → ASB1 (>>) |
| CAV1 → BBC3 (>>) |
| CAV1 → CBS (>>) |
| CAV1 → CCDC3 (>>) |
| CAV1 → CHST7 (>>) |
| CAV1 → CTSF (>>) |
| CAV1 → CXCR7 (>>) |
| CAV1 → DAB2 (>>) |
| CAV1 → DUSP1 (>>) |
| CAV1 → EFEMP1 (>>) |
| CAV1 → EMG1 (>>) |
| CAV1 → EMP1 (>>) |
| CAV1 → FAM100B (>>) |
| CAV1 → FGF7 (>>) |
| CAV1 → FZD4 (>>) |
| CAV1 → GNG11 (>>) |
| CAV1 → HOPX (>>) |
| CAV1 → HOXA3 (>>) |
| CAV1 → IGFBP6 (>>) |
| CAV1 → IL1R1 (>>) |
| CAV1 → ITGA7 (>>) |
| CAV1 → ITGAV (>>) |
| CAV1 → KLF10 (>>) |
| CAV1 → KLF16 (>>) |
| CAV1 → MMP19 (>>) |
| CAV1 → MYLK (>>) |
| CAV1 → PCDH7 (>>) |
| CAV1 → PDE2A (>>) |
| CAV1 → PKIG (>>) |
| CAV1 → PLD1 (>>) |
| CAV1 → POP1 (>>) |
| CAV1 → PPAP2A (>>) |
| CAV1 → PTPRE (>>) |
| CAV1 → ROBO3 (>>) |
| CAV1 → RORA (>>) |
| CAV1 → RPS6KA2 (>>) |
| CAV1 → SCN4B (>>) |
| CAV1 → SESN1 (>>) |
| CAV1 → SOCS3 (>>) |
| CAV1 → SOCS5 (>>) |
| CAV1 → SPRY2 (>>) |
| CAV1 → STEAP1 (>>) |
| CAV1 → TIMP2 (>>) |
| CAV1 → TK1 (>>) |
| CAV1 → TNXB (>>) |
| CAV1 → TWIST1 (>>) |
| CAV1 → VEGFC (>>) |
